Home > Boards > US Listed > Medical - Drugs > Merck & Co. Inc. (MRK)

Someone is accumulating MRK shares in a very

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Prudent Capitalist Member Profile
 
Followed By 79
Posts 12,508
Boards Moderated 5
Alias Born 05/28/09
160x600 placeholder
Merck Hosts 2019 Investor Day Outlining Bus. Momentum, Strong Expected Growth & Focus on Innovative Research & Development Business Wire - 6/20/2019 6:45:00 AM
Merck Seeks Deals As It Expands Its Cancer Treatments -- WSJ Dow Jones News - 6/20/2019 3:02:00 AM
AstraZeneca & Merck’s LYNPARZA® (olaparib) Approved in Japan as First-Line Maintenance Therapy in Patients with BRCA-Mutat... Business Wire - 6/19/2019 6:45:00 AM
Merck Seeks More Deals Dow Jones News - 6/19/2019 5:59:00 AM
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Monotherapy for Patients with Metastatic Small Cell Lung Cancer (SCLC) w... Business Wire - 6/18/2019 6:45:00 AM
LYNPARZA® (olaparib) Approved in the EU for Use as First-Line Maintenance Therapy in Patients With BRCA-Mutated Advanced Ova... Business Wire - 6/18/2019 6:30:00 AM
Drug Firms Sue Over Ad Rule -- WSJ Dow Jones News - 6/15/2019 3:02:00 AM
Drugmakers Sue to Block Federal Rule Requiring Drug Prices in TV Ads Dow Jones News - 6/14/2019 6:27:00 PM
IBM, KPMG, Merck and Walmart to collaborate as part of FDA's program to evaluate the use of blockchain to protect pharmaceuti... PR Newswire (US) - 6/13/2019 8:05:00 AM
FDA Approves Two New Indications for Merck’s KEYTRUDA® (pembrolizumab) Business Wire - 6/11/2019 6:45:00 AM
Merck to Buy Tilos Therapeutics for Up to $773 Million Dow Jones News - 6/10/2019 7:37:00 AM
Merck to Acquire Tilos Therapeutics Business Wire - 6/10/2019 6:45:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:22:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:21:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:21:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:21:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:20:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:20:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:20:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:20:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:19:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:19:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 5:19:01 PM
FDA Approves Merck’s ZERBAXA® (ceftolozane & tazobactam) 3g Dose for the Treatment of Adults with Hospital-Acquired & Vent... Business Wire - 6/3/2019 4:55:00 PM
LYNPARZA® (olaparib) Phase 3 SOLO3 Trial Demonstrated a 72% Objective Response Rate in Patients with Platinum-Sensitive Rela... Business Wire - 6/3/2019 4:15:00 PM
Prudent Capitalist   Monday, 12/03/18 03:21:20 PM
Re: DewDiligence post# 406
Post # of 468 
Someone is accumulating MRK shares in a very big way, based on the low volume but steady rise in the share price of late. Although it has pulled back today just a bit, the recent accumulation has been obvious and substantial.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist